Related Experiment Video
Updated: Jun 5, 2026
07:20
Amide Coupling Reaction for the Synthesis of Bispyridine-based Ligands and Their Complexation to Platinum as Dinuclear Anticancer Agents
Published on: May 28, 2014
Anticancer active illudins: recent developments of a potent alkylating compound class
R Schobert1, S Knauer, S Seibt
1Organic Chemistry Laboratory, University of Bayreuth, Germany.
Current Medicinal Chemistry
|December 25, 2010
Summary
Spirocyclopropanes from the illudin class show anticancer activity. Research explores their mechanisms, metabolism, and synthesis of improved cancer-fighting derivatives, alongside sourcing and isolation methods.
Area of Science:
- Medicinal Chemistry
- Natural Products Chemistry
- Pharmacology
Background:
- Illudins, a class of spirocyclopropanes, possess notable anticancer properties.
- Illudins M and S are well-studied examples with established chemical profiles.
Purpose of the Study:
- To provide a comprehensive overview of anticancer active spirocyclopropanes of the illudin class.
- To discuss recent advancements in illudin research, including mode of action, metabolism, and synthetic strategies.
- To cover biological sources, isolation procedures, and literature up to 2010.
Main Methods:
- Literature review covering the period up to 2010.
- Analysis of synthetic endeavors towards novel illudin derivatives.
- Discussion of biological sourcing and purification techniques for illudins.
Main Results:
- Overview of illudin chemistry, history, and anticancer activity.
- Report on new findings regarding illudin mechanism of action and metabolism.
- Exploration of synthetic routes for enhanced anticancer efficacy and selectivity.
- Discussion of various biological sources and isolation methods for illudins.
Conclusions:
- Illudins represent a promising class of natural products for cancer therapy.
- Ongoing research focuses on optimizing illudin derivatives for improved clinical application.
- Further investigation into sourcing and synthesis is crucial for drug development.
Related Concept Videos
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
02:56Treatment Resistent Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
02:49Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
02:49Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
02:34Inhibition of Cdk Activity
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...